Page last updated: 2024-09-04

13-methyltetradecanoic acid and T-Cell Lymphoma

13-methyltetradecanoic acid has been researched along with T-Cell Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, Q; Chen, K; Huang, H; Lin, T; Luo, J; Qian, D; Tian, Y	1

Other Studies

1 other study(ies) available for 13-methyltetradecanoic acid and T-Cell Lymphoma

Article	Year
13-methyltetradecanoic acid exhibits anti-tumor activity on T-cell lymphomas in vitro and in vivo by down-regulating p-AKT and activating caspase-3. PloS one, 2013, Volume: 8, Issue:6 Topics: Animals; Apoptosis; Blotting, Western; Caspase 3; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Enzyme Activation; G1 Phase Cell Cycle Checkpoints; Lymphoma, T-Cell; Mice; Mice, Nude; Myristic Acids; Neoplasm Proteins; NF-kappa B; Phosphorylation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays	2013

Article

Year

13-methyltetradecanoic acid exhibits anti-tumor activity on T-cell lymphomas in vitro and in vivo by down-regulating p-AKT and activating caspase-3.

PloS one, 2013, Volume: 8, Issue:6

Topics: Animals; Apoptosis; Blotting, Western; Caspase 3; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Enzyme Activation; G1 Phase Cell Cycle Checkpoints; Lymphoma, T-Cell; Mice; Mice, Nude; Myristic Acids; Neoplasm Proteins; NF-kappa B; Phosphorylation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays

2013